AKT1 and cancer: Interestingly, recent studies have reported that miR-424-5p can target PI3K/Akt signaling to accelerate the development of some types of cancer [21,22,23], but whether the enhancement of cancer cachexia induced by miR-424-5p has a definite connection with the PI3K/Akt signaling pathway is still unknown.